Literature DB >> 16769714

Pseudomonas serology: confusion, controversy, and challenges.

P M Farrell, J R W Govan.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16769714      PMCID： PMC2104689          DOI： 10.1136/thx.2006.062612

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  15 in total

1.  Production and characterisation of mouse monoclonal antibodies reactive with the lipopolysaccharide core of Pseudomonas aeruginosa.

Authors:  J W Nelson; G R Barclay; L R Micklem; I R Poxton; J R Govan
Journal:  J Med Microbiol       Date:  1992-05       Impact factor: 2.472

2.  IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA.

Authors:  T Pressler; S S Pedersen; F Espersen; N Høiby; C Koch
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

3.  Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis.

Authors:  J W Nelson; M W Tredgett; J K Sheehan; D J Thornton; D Notman; J R Govan
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Signal detectability and medical decision-making.

Authors:  L B Lusted
Journal:  Science       Date:  1971-03-26       Impact factor: 47.728

5.  Diagnostic value of serological tests against Pseudomonas aeruginosa in a large cystic fibrosis population.

Authors:  G A Tramper-Stranders; C K van der Ent; M G Slieker; S W J Terheggen-Lagro; F Teding van Berkhout; J L L Kimpen; T F W Wolfs
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

6.  Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection.

Authors:  M M Brett; A T Ghoneim; J M Littlewood
Journal:  Arch Dis Child       Date:  1987-04       Impact factor: 3.791

7.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Authors:  G Döring; N Høiby
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.

Authors:  N Hoiby; E W Flensborg; B Beck; B Friis; S V Jacobsen; L Jacobsen
Journal:  Scand J Respir Dis       Date:  1977-04

Review 9.  Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management.

Authors:  Margaret Rosenfeld; Bonnie W Ramsey; Ronald L Gibson
Journal:  Curr Opin Pulm Med       Date:  2003-11       Impact factor: 3.155

10.  Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.

Authors:  Susan E H West; Lan Zeng; Bee Leng Lee; Michael R Kosorok; Anita Laxova; Michael J Rock; Mark J Splaingard; Philip M Farrell
Journal:  JAMA       Date:  2002-06-12       Impact factor: 157.335
View more
  7 in total

1.  Investigating the humoral immune response in chronic venous leg ulcer patients colonised with Pseudomonas aeruginosa.

Authors:  Jasper N Jacobsen; Anders S Andersen; Michael K Sonnested; Inga Laursen; Bo Jorgensen; Karen A Krogfelt
Journal:  Int Wound J       Date:  2010-11-19       Impact factor: 3.315

2.  Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis.

Authors:  Philip M Farrell; Jannette Collins; Lynn S Broderick; Michael J Rock; Zhanhai Li; Michael R Kosorok; Anita Laxova; William M Gershan; Alan S Brody
Journal:  Radiology       Date:  2009-08       Impact factor: 11.105

3.  Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial.

Authors:  Michael Anstead; Sonya L Heltshe; Umer Khan; Joseph T Barbieri; Markus Langkamp; Gerd Döring; Shimoni Dharia; Ronald L Gibson; Miriam M Treggiari; James Lymp; Margaret Rosenfeld; Bonnie Ramsey
Journal:  J Cyst Fibros       Date:  2012-09-01       Impact factor: 5.482

4.  Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis.

Authors:  Aparna R Rao; Anita Laxova; Philip M Farrell; Joseph T Barbieri
Journal:  J Clin Microbiol       Date:  2009-06-24       Impact factor: 5.948

5.  Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening.

Authors:  D Hayes; P M Farrell; Z Li; S E West
Journal:  Pediatr Pulmonol       Date:  2010-01

6.  Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA).

Authors:  Renan Marrichi Mauch; Cláudio Lúcio Rossi; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Marcos Tadeu Nolasco da Silva; Carlos Emílio Levy
Journal:  Diagn Pathol       Date:  2014-08-22       Impact factor: 2.644

Review 7.  Biosensors and Diagnostics for Fungal Detection.

Authors:  Khalil K Hussain; Dhara Malavia; Elizabeth M Johnson; Jennifer Littlechild; C Peter Winlove; Frank Vollmer; Neil A R Gow
Journal:  J Fungi (Basel)       Date:  2020-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.